Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Patient Education and Support

Sponsored by

  • Full Results
    • Winner

      NINLARO Patient Support Programme

      by Takeda UK and Ireland with support from Apodi Limited


      Finalists

      CML LIFE

      by INCYTE with support from Open Health PBC

      Could There Be More?

      by Sobi with support from Say Communications

      Life Effects

      by Teva Pharmaceuticals with support from Red Havas

      Start from Scratch

      by Thornton & Ross with support from Pegasus


Back to Results


Winner

NINLARO Patient Support Programme

by Takeda UK and Ireland with support from Apodi Limited


Summary of work

Takeda and Apodi have developed and deployed a Support Programme for Patients prescribed NINLARO which is fully aligned with Takeda’s core values and Apodi’s model for patient-centricity.

The programme is delivered by experienced NINLARO Specialist Nurses (NSNs), who provide incremental and integrated capacity to NHS units, and deliver high levels of quality patient interactions which can take place in clinic, on the telephone, in the patient’s home, or any combination of these.

At participating hospitals, every NINLARO patient has a named NSN, together with a tailored support plan aligned with their preferences. This drives continuity of care, the best possible experiences and outcomes and helps them, and their Healthcare Professionals (HCPs) to identify and manage toxicities early, thus driving appropriate time on therapy.

The PSP is supported by educational literature for both patients and HCPs which is designed to drive knowledge and confidence in treatment and management.

Feedback from both patients and HCPs demonstrates that the programme is having positive effects on treatment outcomes and is highly valued.

The Programme at each Trust is reviewed regularly by Senior Management at Takeda, Apodi and the Trust to ensure high levels of performance and a culture of continuous improvement.

Judges' comments

The NINLARO programme was an impressive, structured model with great insights and very clear objectives. The metrics were strong, with tangible outcomes and the judges were impressed by the ongoing assessment and management plan. It was a fabulous support programme with patient centricity at its core.


Finalists

CML LIFE - by INCYTE with support from Open Health PBC

Could There Be More? - by Sobi with support from Say Communications

Life Effects - by Teva Pharmaceuticals with support from Red Havas

Start from Scratch - by Thornton & Ross with support from Pegasus


Key dates

Entry deadline 29 August 2019
Extended entry deadline 5 September 2019*
*additional fee applies
Judging day 26 September 2019
Company/Team Interviews 9 October 2019
PMEA Event 27 November 2019